In the United States, although republicans, democrats and the President all seem to agree that the nation’s aging infrastructure is…
McAlinden Research PartnersOctober 31, 2019
New developments in CRISPR gene editing technology have opened the door to potential cures for 89% of known disease-causing genetic…
McAlinden Research PartnersOctober 29, 2019
Coal’s decline is about to accelerate due to plunging renewable energy costs, rock-bottom natural gas prices, rising carbon credit prices,…
McAlinden Research PartnersOctober 28, 2019
The “lab-grown” phenomenon isn’t disrupting just food production. It has hit the $80 billion diamond industry as well. The technology…
McAlinden Research PartnersOctober 24, 2019
As the massive 2700-case litigation against major producers and distributors of opioids continues in Ohio, many lawyers and Attorneys General…
McAlinden Research PartnersOctober 23, 2019
As of Monday’s close, Boeing stock is down over 11% in the last week, largely due to the release of…
McAlinden Research PartnersOctober 22, 2019
The prevalence of chronic diseases combined with their sky-high price tags is drawing interest to digital therapeutics (DTx), a new…
McAlinden Research PartnersOctober 21, 2019
Although the firearms industry has been in a slump since late 2016, there are some indications that it may be…
McAlinden Research PartnersOctober 17, 2019
A painful planting season has turned to harvesting season for US farmers, but shortfalls continue to persist. The USDA has…
McAlinden Research PartnersOctober 16, 2019
